DNAVSGRAL• 28 Days (Normalized)
DNA vs GRAL (Ginkgo Bioworks Holdings Inc. vs GRAIL Inc.)
Showing Closing Date Range from Sep 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
GRAL Performance $136.57
+69.53%
GRAIL Inc.
Normalized Baseline0.00%
Alpha Spread Margin GRAL LEADS
-69.53 pts
GRAL outperforming by 69.53 percentage points
DNAGRAL
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA GRAL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | DNA Price | DNA Gain (%) | GRAL Price | GRAL Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $136.57 | +69.53% | - | |
| Sep 28, 2026 | $10.46 | +48.79% | $132.63 | +64.64% | -15.85% |
| Sep 25, 2026 | $10.66 | +51.64% | $126.89 | +57.51% | -5.87% |
| Sep 24, 2026 | $10.25 | +45.80% | $125.21 | +55.42% | -9.62% |
| Sep 23, 2026 | $8.58 | +22.05% | $108.52 | +34.71% | -12.66% |
| Sep 22, 2026 | $9.37 | +33.29% | $108.52 | +34.71% | -1.42% |
| Sep 21, 2026 | $7.98 | +13.51% | $107.97 | +34.02% | -20.51% |
| Sep 18, 2026 | $7.88 | +12.09% | $80.77 | +0.26% | +11.83% |
| Sep 17, 2026 | $7.84 | +11.52% | $79.95 | -0.76% | +12.28% |
| Sep 16, 2026 | $7.06 | +0.43% | $75.11 | -6.77% | +7.20% |
| Sep 15, 2026 | $6.99 | -0.57% | $75.89 | -5.80% | +5.23% |
| Sep 14, 2026 | $7.01 | -0.28% | $75.53 | -6.24% | +5.96% |
| Sep 11, 2026 | $6.75 | -3.98% | $76.23 | -5.37% | +1.39% |
| Sep 10, 2026 | $6.78 | -3.56% | $77.56 | -3.72% | +0.16% |
| Sep 09, 2026 | $6.79 | -3.41% | $77.48 | -3.82% | +0.41% |
Page 1 of 2